Regulation of apolipoprotein A-I gene expression by ascorbic acid in scurvy-prone ODS-od/od rats.
抗坏血酸对易患坏血病的 ODS-od/od 大鼠中载脂蛋白 A-I 基因表达的调节。
基本信息
- 批准号:05660136
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Apolipoprotein A-I (Apo A-I) is a major apolipoprotein of serum high density lipoprotein (HDL) , which transports cholesterol from peripheral tissues to liver. We observed that apo A-I in serum HDL was decreased in ascorbic acid (AsA) deficiency in scurvy-prone ODS-od/od rats. In this study, we examined the mechanism how AsA deficiency causes a low level Apo A-I in serum.The Apo A-I mRNA level in the liver but not in the small intestine was decreased (50%) in AsA-deficient group compared to in the control group. As AsA deficiency did not affect the transcription rate of Apo A-I gene, AsA might be required to stabilize Apo A-I mRNA.Moreover, a lower level of albumin mRNA,a higher level of haptoglobin mRNA and a higher level of 1-acid glycoprotein mRNA in the liver was observed in ascorbic acid-deficienct rats compared to in the control rats. These changes in hepatic levels of mRNA including Apo A-I mRNA are also observed in acute phase or inflammation. At present, we are measuring the serum levels of interleukin-6, which is a major cytokine secreted in acute phase and inflammation, in ascorbic acid deficiency.
载脂蛋白A-I(ApoA-I)是血清高密度脂蛋白(HDL)的主要载脂蛋白,负责将胆固醇从外周组织转运至肝脏。我们观察到抗坏血酸(阿萨)缺乏可使易患坏血病的ODS-od/od大鼠血清HDL中apo A-I降低。在本研究中,我们探讨了阿萨缺乏导致血清中Apo A-I水平降低的机制,发现与对照组相比,AsA缺乏组肝脏中的Apo A-I mRNA水平降低了50%,而小肠中的Apo A-I mRNA水平没有降低。由于阿萨缺乏不影响Apo A-I基因的转录速率,因此可能需要阿萨来稳定Apo A-I mRNA,而且与对照组相比,抗坏血酸缺乏大鼠肝脏中白蛋白mRNA水平降低,结合珠蛋白mRNA水平升高,1-酸性糖蛋白mRNA水平升高。在急性期或炎症中也观察到肝脏mRNA(包括Apo A-I mRNA)水平的这些变化。目前,我们正在测定抗坏血酸缺乏时血清中白细胞介素-6的水平,白细胞介素-6是急性期和炎症中分泌的主要细胞因子。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ikeda, S.: "Ascorbate deficiency decreases hepatic apolipoprotein A-I mRNA in a scurvy-prone rat (genotype ODS-od/od)." Biochem.J.(submitted.).
Ikeda, S.:“抗坏血酸缺乏会降低坏血病倾向大鼠(基因型 ODS-od/od)的肝载脂蛋白 A-I mRNA。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Uchida,K.: "Acute nephrotoxicity of a carcinogenic iron chelate selective inhibition of a proteolytic conversion of 2u-globulin to the kidney fatty acid-binding protein." FEBS Letters. 357. 165-167 (1995)
Uchida,K.:“致癌铁螯合物的急性肾毒性选择性抑制 2u-球蛋白向肾脂肪酸结合蛋白的蛋白水解转化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Uchida,K.: "Acute nephrotoxicity of a carcinogenic iron chelate selective inhibition of a proteolytic conversion of 2n-globulin to the Kidney fatty acid-binding protein." FEBS Letters. 357. 165-167 (1995)
Uchida,K.:“致癌铁螯合物的急性肾毒性选择性抑制 2n-球蛋白向肾脂肪酸结合蛋白的蛋白水解转化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ikeda,S.: "Ascorbate deficiency decreases hepatic apolopoprotein A-I mRNA in a scurvy-prone rat(genotype ODS-od/od)." Biochem.J,.submitted.
Ikeda,S.:“抗坏血酸缺乏会降低坏血病倾向大鼠(基因型 ODS-od/od)的肝载脂蛋白 A-I mRNA。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORIO Fumihiko其他文献
HORIO Fumihiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORIO Fumihiko', 18)}}的其他基金
Identification of diabetogenic and obesity genes by using nucleotides sequence variations between SM/J and A/J mice.
利用 SM/J 和 A/J 小鼠之间的核苷酸序列变异鉴定糖尿病和肥胖基因。
- 批准号:
24380068 - 财政年份:2012
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pioneer study on the protective effect of ascorbic acid on barrier function of gastrointestinal tract
抗坏血酸对胃肠道屏障功能保护作用的开创性研究
- 批准号:
22658042 - 财政年份:2010
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Identification of the diabetogenic gene and its related genes of high fat diet-induced diabetes by using novel mouse model
利用新型小鼠模型鉴定高脂饮食诱发糖尿病的致糖尿病基因及其相关基因
- 批准号:
21380079 - 财政年份:2009
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of causative gene for type 2 diabetes in SMXA-5 mouse feeding a high fat diet.
鉴定喂养高脂肪饮食的 SMXA-5 小鼠 2 型糖尿病致病基因。
- 批准号:
15580105 - 财政年份:2003
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The analysis of inflammation-like response caused by ascorbic acid deficiency in ODS rats unable to synthesize ascorbic acid.
无法合成抗坏血酸的ODS大鼠抗坏血酸缺乏引起的炎症样反应分析。
- 批准号:
13660121 - 财政年份:2001
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a novel strain of spontaneously hypertensive rat with a defect of ascorbic acid biosynthesis, and the effect of ascorbic acid deficiency on the hypertension
抗坏血酸生物合成缺陷型自发性高血压大鼠新品系的建立及抗坏血酸缺乏对高血压的影响
- 批准号:
11660125 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic analysis of diabetes in SMXA recombinant inbred strain of mice.
SMXA重组近交系小鼠糖尿病的遗传分析。
- 批准号:
11556024 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of acute phase protein gene expression by ascorbic acid.
抗坏血酸对急性期蛋白基因表达的调节。
- 批准号:
09660134 - 财政年份:1997
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The roles of bilirubin and ascorbic acid as physiological antioxidant against oxidative stress.
胆红素和抗坏血酸作为生理抗氧化剂对抗氧化应激的作用。
- 批准号:
07660160 - 财政年份:1995
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
New diagnostic and therapeutic strategies for atherosclerosis using newly developed apolipoprotein A-I mimetic peptide
使用新开发的载脂蛋白 A-I 模拟肽治疗动脉粥样硬化的新策略
- 批准号:
24591123 - 财政年份:2012
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Apolipoprotein A-I Mimetic Peptides: a Research Tool and a Therapeutic Agent to Study and Treat Atherosclerosis
新型载脂蛋白 A-I 模拟肽:研究和治疗动脉粥样硬化的研究工具和治疗剂
- 批准号:
nhmrc : 1003106 - 财政年份:2011
- 资助金额:
$ 1.41万 - 项目类别:
NHMRC Project Grants
Animal model of autoimmune-induced atherosclerosis : Clinical significance of autoantibody against apolipoprotein A-I
自身免疫性动脉粥样硬化动物模型:载脂蛋白A-I自身抗体的临床意义
- 批准号:
08557133 - 财政年份:1996
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ATHEROSCLEROSIS AND APOLIPOPROTEIN A-I REGULATION
动脉粥样硬化和载脂蛋白 A-I 调节
- 批准号:
3472495 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
ATHEROSCLEROSIS AND APOLIPOPROTEIN A-I REGULATION
动脉粥样硬化和载脂蛋白 A-I 调节
- 批准号:
3472492 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
ATHEROSCLEROSIS AND APOLIPOPROTEIN A-I REGULATION
动脉粥样硬化和载脂蛋白 A-I 调节
- 批准号:
3472494 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
ATHEROSCLEROSIS AND APOLIPOPROTEIN A-I REGULATION
动脉粥样硬化和载脂蛋白 A-I 调节
- 批准号:
2220202 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
ATHEROSCLEROSIS AND APOLIPOPROTEIN A-I REGULATION
动脉粥样硬化和载脂蛋白 A-I 调节
- 批准号:
3472493 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS
载脂蛋白A-I基因多态性与动脉粥样硬化
- 批准号:
3348940 - 财政年份:1985
- 资助金额:
$ 1.41万 - 项目类别:
APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS
载脂蛋白A-I基因多态性与动脉粥样硬化
- 批准号:
3348942 - 财政年份:1985
- 资助金额:
$ 1.41万 - 项目类别: